Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs ELDER PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES ELDER PHARMA SUVEN LIFE SCIENCES/
ELDER PHARMA
 
P/E (TTM) x -20.5 -1.0 - View Chart
P/BV x 5.8 0.1 5,757.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 SUVEN LIFE SCIENCES   ELDER PHARMA
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-23
ELDER PHARMA
Jun-14
SUVEN LIFE SCIENCES/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs94380 24.7%   
Low Rs45188 23.9%   
Sales per share (Unadj.) Rs0.6489.2 0.1%  
Earnings per share (Unadj.) Rs-5.4-3.2 170.6%  
Cash flow per share (Unadj.) Rs-5.114.4 -35.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs17.2376.5 4.6%  
Shares outstanding (eoy) m218.0720.54 1,061.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x111.80.6 19,253.0%   
Avg P/E ratio x-12.8-89.3 14.3%  
P/CF ratio (eoy) x-13.519.7 -68.7%  
Price / Book Value ratio x4.00.8 534.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,1315,832 259.4%   
No. of employees `000NANA-   
Total wages/salary Rs m1862,179 8.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m13510,048 1.3%  
Other income Rs m84257 32.9%   
Total revenues Rs m22010,305 2.1%   
Gross profit Rs m-1,1962,921 -41.0%  
Depreciation Rs m65361 18.1%   
Interest Rs m52,756 0.2%   
Profit before tax Rs m-1,18360 -1,976.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0125 0.0%   
Profit after tax Rs m-1,183-65 1,810.9%  
Gross profit margin %-883.629.1 -3,039.8%  
Effective tax rate %0209.1 -0.0%   
Net profit margin %-873.5-0.6 134,395.4%  
BALANCE SHEET DATA
Current assets Rs m3,4559,240 37.4%   
Current liabilities Rs m1,0509,998 10.5%   
Net working cap to sales %1,776.0-7.5 -23,552.5%  
Current ratio x3.30.9 355.9%  
Inventory Days Days3,948128 3,078.2%  
Debtors Days Days218602 36.2%  
Net fixed assets Rs m1,37313,642 10.1%   
Share capital Rs m218206 106.0%   
"Free" reserves Rs m3,5357,528 47.0%   
Net worth Rs m3,7537,733 48.5%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m4,82822,882 21.1%  
Interest coverage x-218.81.0 -21,417.8%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x00.4 6.4%   
Return on assets %-24.411.8 -207.3%  
Return on equity %-31.5-0.8 3,731.4%  
Return on capital %-31.422.3 -140.6%  
Exports to sales %40.43.1 1,325.4%   
Imports to sales %839.80.4 195,773.6%   
Exports (fob) Rs m55307 17.9%   
Imports (cif) Rs m1,13743 2,638.1%   
Fx inflow Rs m55307 17.9%   
Fx outflow Rs m1,137125 907.7%   
Net fx Rs m-1,082181 -596.9%   
CASH FLOW
From Operations Rs m-1,03111,754 -8.8%  
From Investments Rs m-2,606-561 465.0%  
From Financial Activity Rs m3,955-6,762 -58.5%  
Net Cashflow Rs m3175,466 5.8%  

Share Holding

Indian Promoters % 69.6 25.3 274.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 24.0 2.3%  
FIIs % 0.5 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 74.7 40.8%  
Shareholders   74,003 31,548 234.6%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Suven Life Sciences vs Elder Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Suven Life Sciences vs Elder Pharma Share Price Performance

Period Suven Life Sciences Elder Pharma S&P BSE HEALTHCARE
1-Day 0.60% 4.97% 1.18%
1-Month -1.77% 21.21% -0.75%
1-Year 115.56% -64.54% 61.82%
3-Year CAGR 15.06% -51.65% 18.16%
5-Year CAGR -16.16% -37.46% 19.79%

* Compound Annual Growth Rate

Here are more details on the Suven Life Sciences share price and the Elder Pharma share price.

Moving on to shareholding structures...

The promoters of Suven Life Sciences hold a 69.6% stake in the company. In case of Elder Pharma the stake stands at 25.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Suven Life Sciences and the shareholding pattern of Elder Pharma.

Finally, a word on dividends...

In the most recent financial year, Suven Life Sciences paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Elder Pharma paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Suven Life Sciences, and the dividend history of Elder Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.